Diabetes News and Research

Latest Diabetes News and Research

Free Rite Aid wellness+ customer rewards program

Rite Aid customers and patients nationwide now can sign up for Rite Aid's new wellness+ customer rewards program that provides members with free health and wellness benefits, as well as shopping discounts and special prices. The program will be supported by a national television, radio, circular and digital advertising campaign.

20 Apr 2010

Canadian Diabetes Association recognizes world-class volunteers

In the spirit of National Volunteer Week, the Canadian Diabetes Association would like to send a sincere message of gratitude to the more than 35,000 community and professional volunteers who selflessly give their time each and every day to help advance the battle against diabetes.

20 Apr 2010

FDA-approved metformin can prevent tobacco-carcinogen induced lung tumors: Study

Metformin, a mainstay of treatment for patients with type 2 diabetes, may soon play a role in lung cancer prevention if early laboratory research presented here at the AACR 101st Annual Meeting 2010 is confirmed in clinical trials.

20 Apr 2010

Even modest weight loss brings many health benefits

There have been repeated warnings related to the growing obese and diabetes related population in Australia. Studies have shown that nearly 50% Australians are either obese or overweight and thus suffer from its ill effects like heart disease, high cholesterol and type II diabetes.

20 Apr 2010

Atherotech to showcase VAP Cholesterol Test at Internal Medicine 2010

Atherotech Inc. announced it will exhibit its VAP® Cholesterol Test in booth #1305 at Internal Medicine 2010, the annual scientific meeting of the American College of Physicians (ACP). The meeting takes place April 22-24, 2010, at the Metro Toronto Convention Centre in Toronto, Canada.

20 Apr 2010

Encorium Group reports 21.4% decrease in fourth-quarter net revenue

Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.

20 Apr 2010

FTO gene associated with loss of brain tissue: UCLA researchers

Three years ago, geneticists reported the startling discovery that nearly half of all people in the U.S. with European ancestry carry a variant of the fat mass and obesity associated gene, which causes them to gain weight - from three to seven pounds, on average - but worse, puts them at risk for obesity.

20 Apr 2010

OECs may hold promise for pediatric cerebral palsy treatment

A unique cell type that supports and surrounds (ensheathes) neurons within the nose (olfactory system) known as olfactory ensheathing cells (OECs), possess the ability to regenerate, are relatively easy to obtain, and have become prime candidates for transplantation to repair a number of lesions in the central nervous system (CNS).

19 Apr 2010

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has established an action plan for obtaining cost reimbursement coverage for Generex Oal-lyn™, including the development of an insurance product that covers the costs of Generex Oral-lyn™ and any additional and/or comparable diabetes products.

19 Apr 2010

Laparoscopic sleeve gastrectomy receives health insurance coverage

The American Society for Metabolic and Bariatric Surgery (ASMBS) today announced its support of recent policy changes by Aetna Inc. and United Healthcare. The national health insurance giants will now cover laparoscopic sleeve gastrectomy, a newer method of bariatric surgery that is becoming increasingly popular as a treatment for morbid obesity.

19 Apr 2010

Amylin Pharmaceuticals announces $174.1M total revenue for first-quarter 2010

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010. The Company reported total revenue of $174.1 million for the quarter ended March 31, 2010, which includes net product sales of $172.3 million. Non-GAAP operating loss was $3.8 million for the quarter ended March 31, 2010, compared to $19.9 million for the same period in 2009.

19 Apr 2010

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.

19 Apr 2010

Trans fats back on the agenda in UK

Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.

19 Apr 2010

Heart transplant patient skis to the North Pole

They made it! In what is believed to be a world-first, a heart transplant patient along with his transplant doctor skied over 100 miles, over ice, snow drifts, across open water, through gale-force winds and freezing temperatures to make it to the North Pole early Thursday morning.

17 Apr 2010

Racial disparities in sleep and health-related quality of life

A study in the April 15 issue of the Journal of Clinical Sleep Medicine shows that having a sleep disturbance is associated with clinically meaningful reductions in health-related quality of life, and the magnitude of this effect varies by race and sleep disorder.

17 Apr 2010

MEDIHONEY dressings serve as low-cost method for treating wounds in indigent patients

Using a particular brand of medical honey dressing may be a safe, effective and low-cost method of treating chronic, non-healing wounds in indigent patients, according to a poster presented at the Symposium on Advanced Wound Care and the Wound Healing Society, an international conference drawing clinicians from all over the globe, which was held April 17-20 in Orlando.

17 Apr 2010

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

A National Cancer Clinical Trials System For The 21st Century: Reinvigorating The NCI Cooperative Group Program - The "system for conducting cancer clinical trials in the United States is approaching a state of crisis," according to this report on inefficiencies and funding issues faced by the NCI's Clinical Trials Cooperative Group Program - which comprises 10 groups, more than 3,100 institutions, 14,000 investigators and more than 25,000 patients in clinical trials each year.

17 Apr 2010

MU researchers determine efficient method for assessing body composition

Measuring body composition - the amount of fatty tissue, muscle tissue and bone present in the body - can provide valuable information for determining an individual's overall health status. However, obtaining accurate measurements can be difficult and expensive, according to Steve Ball, University of Missouri Extension fitness specialist.

17 Apr 2010

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

The Translational Genomics Research Institute and Asuragen Inc. today announced a research agreement that could lead to ways of detecting cancer before it spreads.

17 Apr 2010

Researchers discover link between protein structure and hearing process

Rising from the top surface of each of the specialized receptor cells in our inner ears is a bundle of sensory cilia that responds to the movement of sound. As sensitive as they are fragile, these cilia can move to wisps of sound no larger than a molecule-but can shear at sounds that are larger than life.

17 Apr 2010

Diabetes News and Research

Latest Diabetes News and Research

Free Rite Aid wellness+ customer rewards program

Canadian Diabetes Association recognizes world-class volunteers

FDA-approved metformin can prevent tobacco-carcinogen induced lung tumors: Study

Even modest weight loss brings many health benefits

Atherotech to showcase VAP Cholesterol Test at Internal Medicine 2010

Encorium Group reports 21.4% decrease in fourth-quarter net revenue

FTO gene associated with loss of brain tissue: UCLA researchers

OECs may hold promise for pediatric cerebral palsy treatment

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

Laparoscopic sleeve gastrectomy receives health insurance coverage

Amylin Pharmaceuticals announces $174.1M total revenue for first-quarter 2010

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Trans fats back on the agenda in UK

Heart transplant patient skis to the North Pole

Racial disparities in sleep and health-related quality of life

MEDIHONEY dressings serve as low-cost method for treating wounds in indigent patients

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

MU researchers determine efficient method for assessing body composition

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

Researchers discover link between protein structure and hearing process

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in